113 related articles for article (PubMed ID: 26086762)
1. Thalassemia Modular Stratification System for Personalized Therapy of Beta-Thalassemia (THALAMOSS).
Hum Gene Ther Clin Dev; 2015 Jun; 26(2):100-2. PubMed ID: 26086762
[No Abstract] [Full Text] [Related]
2. Severe β-thalassemia intermedia in a compound heterozygous patient for the -30 (T>A) β(+)-thalassemia mutation and the δ(0)β(+)-Senegalese deletion.
Griffon C; Joly P; Sénéchal A; Philit F; Francina A
Hemoglobin; 2010; 34(5):505-8. PubMed ID: 20854126
[TBL] [Abstract][Full Text] [Related]
3. Recent Progress on Genetic Diagnosis and Therapy for β-Thalassemia in China and Around the World.
Zhang J; Yan J; Zeng F
Hum Gene Ther; 2018 Feb; 29(2):197-203. PubMed ID: 29357712
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy. Beta-thalassemia treatment succeeds, with a caveat.
Kaiser J
Science; 2009 Dec; 326(5959):1468-9. PubMed ID: 20007873
[No Abstract] [Full Text] [Related]
5. First gene therapy for β-thalassemia approved.
Harrison C
Nat Biotechnol; 2019 Oct; 37(10):1102-1103. PubMed ID: 31578501
[No Abstract] [Full Text] [Related]
6. Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia.
Farashi S; Bayat N; Faramarzi Garous N; Ashki M; Montajabi Niat M; Vakili S; Imanian H; Zeinali S; Najmabadi H; Azarkeivan A
Hemoglobin; 2015; 39(3):201-6. PubMed ID: 26084319
[TBL] [Abstract][Full Text] [Related]
7. Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells.
Patsali P; Turchiano G; Papasavva P; Romito M; Loucari CC; Stephanou C; Christou S; Sitarou M; Mussolino C; Cornu TI; Antoniou MN; Lederer CW; Cathomen T; Kleanthous M
Haematologica; 2019 Nov; 104(11):e497-e501. PubMed ID: 31004018
[No Abstract] [Full Text] [Related]
8. Gene therapy: Targeting β-thalassaemia.
Persons DA
Nature; 2010 Sep; 467(7313):277-8. PubMed ID: 20844523
[No Abstract] [Full Text] [Related]
9. Impact of β-globin mutations on outcome of matched related donor hematopoietic stem cell transplantation for patients with β-thalassemia major.
Hamidieh AA; Saber T; Fayyazi S; Jalali A; Behfar M; Hamdi A; Ghavamzadeh A
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1772-6. PubMed ID: 25017762
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin gene therapy for β-thalassemia.
Bank A
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
[TBL] [Abstract][Full Text] [Related]
11. Genetic determinants of β-thalassemia intermedia in Pakistan.
Khan J; Ahmad N; Siraj S; Hoti N
Hemoglobin; 2015; 39(2):95-101. PubMed ID: 25707679
[TBL] [Abstract][Full Text] [Related]
12. Co-inheritance of novel ATRX gene mutation and globin (α & β) gene mutations in transfusion dependent beta-thalassemia patients.
Al-Nafie AN; Borgio JF; AbdulAzeez S; Al-Suliman AM; Qaw FS; Naserullah ZA; Al-Jarrash S; Al-Madan MS; Al-Ali RA; AlKhalifah MA; Al-Muhanna F; Steinberg MH; Al-Ali AK
Blood Cells Mol Dis; 2015 Jun; 55(1):27-9. PubMed ID: 25976463
[TBL] [Abstract][Full Text] [Related]
13. Insight onto the pathophysiology and clinical complications of thalassemia intermedia.
Cappellini MD; Musallam KM; Taher AT
Hemoglobin; 2009; 33 Suppl 1():S145-59. PubMed ID: 20001620
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for beta thalassemia.
Stower H
Nat Med; 2018 Dec; 24(12):1781. PubMed ID: 30523322
[No Abstract] [Full Text] [Related]
15. The importance of β globin deletion analysis in the evaluation of patients with β thalassemia.
Mikula M; Buller-Burckle A; Gallivan M; Sun W; Franklin CR; Strom CM
Int J Lab Hematol; 2011 Jun; 33(3):310-7. PubMed ID: 21219590
[TBL] [Abstract][Full Text] [Related]
16. Hb E/β-thalassemia: the second most common cause of transfusion-dependent thalassemia in the Gwalior-Chambal region of Central India.
Kumar R; Sharma DC; Kishor P
Hemoglobin; 2012; 36(5):485-90. PubMed ID: 22738610
[TBL] [Abstract][Full Text] [Related]
17. Thalassemia syndromes in Serbia: an update.
Radmilovic M; Zukic B; Stankovic B; Karan-Djurasevic T; Stojiljkovic M; Spasovski V; Tosic N; Dokmanovic L; Janic D; Pavlovic S
Hemoglobin; 2010; 34(5):477-85. PubMed ID: 20854122
[TBL] [Abstract][Full Text] [Related]
18. Genetic determinants of phenotype in beta-thalassemia.
Panigrahi I; Agarwal S
Hematology; 2008 Aug; 13(4):247-52. PubMed ID: 18796252
[TBL] [Abstract][Full Text] [Related]
19. A novel β(0)-thalassemia frameshift mutation: [HBB:c.216delT].
Konialis C; Hagnefelt B; Sevastidou S; Pispili K; Pangalos C
Hemoglobin; 2012; 36(6):586-8. PubMed ID: 23106651
[TBL] [Abstract][Full Text] [Related]
20. The first report of a homozygous codons 9/10 (+T) β-thalassemia mutation in a Turkish patient.
Unal S; Chui DH; Luo HY; Okur H; Oymak Y; Gumruk F
Hemoglobin; 2015; 39(1):66-8. PubMed ID: 25572182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
